histone deacetylase 1/2 inhibitors (Regenacy Pharmaceuticals)

N/A

Report date: 2025/06/11 10:48:09
NME

Base Information

Drug Namehistone deacetylase 1/2 inhibitors (Regenacy Pharmaceuticals)
Drug Alias NameRCY-1305RCY-2014ACY-1305
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase 1 inhibitorsCNS modulatorsHistone deacetylase 2 inhibitors
TargetsHistone deacetylase 2Histone deacetylase 1
Therapy Area/IndicationsMental DisordersNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcetylon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRegenacy Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsMental DisordersNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A